Company intelligence
MY01
Real-Time Data, Actionable Insights, Improved Outcomes - powered by the Continuous Perfusion Sensing Technology Platform
About MY01
Founded in 2019 and based in Montreal, MY01 envisions a world where every disease is quantifiable, allowing for precise, personalized care for all patients. Specializing in the management of compartment syndrome, our Continuous Perfusion Sensing Technology (CPST) Platform has the potential to transform trauma programs by translating complex biological signs into dynamic, actionable, real-time data that supports better decision-making. This reduces variations in care and delivers improved outcomes, enabling hospitals to allocate resources as efficiently as possible.
Verified activity
Signals from MY01
3 published signals
Research & Knowledge
MY01 is featured in a recent article by The Science Times exploring how health technology advances change the way we detect and respond to medical crises, with an example of real-time muscle perfusion monitoring used by the company to give clinicians continuous insight into physiological changes following traumatic injury.
Reported by MY01
Research & Knowledge
MY01's Dr. Samir Mehta and his team collected blood samples from patients who healed, experienced delayed healing, or did not heal and used gene chip analysis to compare the groups and identify potential differences.
Reported by MY01
Research & Knowledge
MY01 published continuous, objective data ruling out compartment syndrome in a 44-year-old man with a motorcycle accident presenting with orthopedic injuries.
Reported by MY01